Conclusions of JAK Inhibitor vs Systemic Immunosuppressant Safety Study
September 6th 2023Christopher Bunick, MD, PhD, presents the conclusions and major take-aways of the study comparing the safety of Janus Kinase (JAK) inhibitors and systemic immunosuppressants in the treatment of atopic dermatitis (AD).
Role of Advanced Practice Providers in Plaque Psoriasis Treatment Follow-Up
September 6th 2023Lakshi Aldredge, MSN, ANP-BC, comments on the role of nurse practitioners and physician assistants in plaque psoriasis treatment management. Jennifer Conner, MPAS, PA-C, reviews the long-term considerations with systemic therapy.
A Patient’s Experience of Atopic Dermatitis Initial Symptoms and Impact on QoL
September 6th 2023Jennifer Holman, MD, FAAD, and her patient, Audrey Dean, discuss Audrey’s initial symptoms and how the disease impacted her quality of life (QoL). Jennifer Holman reflects on how her practice and approaches have changed as she learned more about the daily impact of atopic dermatitis.